Literature DB >> 27543610

Clozapine-induced dysphagia with secondary substantial weight loss.

Mugtaba Osman1, Vekneswaran Devadas1.   

Abstract

Dysphagia is listed as a 'rare' side effect following clozapine treatment. In this case report, we describe how significant clozapine-induced dysphagia has led to significant reduction of nutritional intake with subsequent substantial weight loss. An 18-year-old single man with an established diagnosis of treatment-resistant paranoid schizophrenia recovered well on a therapeutic dose of clozapine. However, he was noted to lose weight significantly (up to 20% of his original weight) as the dose was uptitrated. This was brought about by development of dysphagia, likely to be due to clozapine. Addition of nutritional supplementary liquids and initiation of a modified behavioural dietary/swallowing programme, while repeatedly mastering the Mendelsohn manoeuvre technique, alleviated the swallowing difficulties and restored his weight. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27543610      PMCID: PMC5015161          DOI: 10.1136/bcr-2016-216445

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  39 in total

Review 1.  Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action.

Authors:  S Sanyal; H H Van Tol
Journal:  J Psychiatr Res       Date:  1997 Mar-Apr       Impact factor: 4.791

2.  Use of antacid medication in patients receiving clozapine: a comparison with other second-generation antipsychotics.

Authors:  David Taylor; Olubanke Olofinjana; Tamanna Rahimi
Journal:  J Clin Psychopharmacol       Date:  2010-08       Impact factor: 3.153

3.  Dysphagia due to olanzepine, an antipsychotic medication.

Authors:  Rajesh Sagar; Sunny T Varghese; Yatan Pal Singh Balhara
Journal:  Indian J Gastroenterol       Date:  2005 Jan-Feb

4.  Clozapine-induced weight loss?

Authors:  Francisco Appiani; Brendan T Carroll; Camilo Muñoz; Juan Trecco
Journal:  Ann Clin Psychiatry       Date:  2011-08       Impact factor: 1.567

Review 5.  Treatment of clozapine-associated weight gain: a systematic review.

Authors:  Z Whitney; R M Procyshyn; D H Fredrikson; A M Barr
Journal:  Eur J Clin Pharmacol       Date:  2015-01-28       Impact factor: 2.953

6.  Clozapine-associated weight loss.

Authors:  R Hanwella; V de Silva; C Wijeratne; T Ketharanathan; J de Silva
Journal:  J Psychopharmacol       Date:  2009-03-05       Impact factor: 4.153

7.  [Dysphagia or dysphagias during neuroleptic medication?].

Authors:  N Chaumartin; M Monville; B Lachaux
Journal:  Encephale       Date:  2011-10-11       Impact factor: 1.291

8.  Clozapine acts as an agonist at serotonin 2A receptors to counter MK-801-induced behaviors through a βarrestin2-independent activation of Akt.

Authors:  Cullen L Schmid; John M Streicher; Herbert Y Meltzer; Laura M Bohn
Journal:  Neuropsychopharmacology       Date:  2014-02-17       Impact factor: 7.853

9.  Polymorphisms of the leptin and HTR2C genes and clozapine-induced weight change and baseline BMI in patients with chronic schizophrenia.

Authors:  Shi Hyun Kang; Jong-il Lee; Hye Ree Han; Minah Soh; Jin Pyo Hong
Journal:  Psychiatr Genet       Date:  2014-12       Impact factor: 2.458

10.  Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations.

Authors:  Jungjin Kim; Eric Macmaster; Thomas L Schwartz
Journal:  Drugs Context       Date:  2014-04-09
View more
  2 in total

Review 1.  Swallowing Disorders in Schizophrenia.

Authors:  Deepika P Kulkarni; Vandan D Kamath; Jonathan T Stewart
Journal:  Dysphagia       Date:  2017-04-26       Impact factor: 3.438

Review 2.  Dysphagia: Thinking outside the box.

Authors:  Hamish Philpott; Mayur Garg; Dunya Tomic; Smrithya Balasubramanian; Rami Sweis
Journal:  World J Gastroenterol       Date:  2017-10-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.